These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28542378)

  • 21. Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant.
    Brédart A; De Pauw A; Anota A; Tüchler A; Dick J; Müller A; Kop JL; Rhiem K; Schmutzler R; Devilee P; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2021 Dec; 60():38-44. PubMed ID: 34455229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global celebrities' effect on health awareness among Jordanians: A study using the case of Angelina Jolie.
    Al-Hussaini M; Ammar K; Kasasbeh N; Sultan H; Al-Omari A
    J Genet Couns; 2019 Oct; 28(5):1021-1028. PubMed ID: 31386265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.
    Russo A; Calò V; Agnese V; Bruno L; Corsale S; Augello C; Gargano G; Barbera F; Cascio S; Intrivici C; Rinaldi G; Gulotta G; Macaluso M; Surmacz E; Giordano A; Gebbia N; Bazan V
    Breast Cancer Res Treat; 2007 Nov; 105(3):267-76. PubMed ID: 17221156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Angelina effect: immediate reach, grasp, and impact of going public.
    Borzekowski DL; Guan Y; Smith KC; Erby LH; Roter DL
    Genet Med; 2014 Jul; 16(7):516-21. PubMed ID: 24357847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences.
    Pieterse AH; Ausems MG; Van Dulmen AM; Beemer FA; Bensing JM
    Am J Med Genet A; 2005 Aug; 137(1):27-35. PubMed ID: 16007615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial.
    Albada A; van Dulmen S; Bensing JM; Ausems MG
    Breast Cancer Res; 2012 Mar; 14(2):R37. PubMed ID: 22394647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
    Arai M; Iwase T; Takazawa Y; Takeshima N
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
    Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
    Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
    Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
    Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
    Evans DG; Barwell J; Eccles DM; Collins A; Izatt L; Jacobs C; Donaldson A; Brady AF; Cuthbert A; Harrison R; Thomas S; Howell A; ; ; Miedzybrodzka Z; Murray A
    Breast Cancer Res; 2014 Sep; 16(5):442. PubMed ID: 25510853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.
    Herold N; Bredow K; Ernst C; Tüchler A; Blümcke B; Waha A; Keser E; Hauke J; Wappenschmidt B; Hahnen E; Schmutzler RK; Rhiem K
    J Genet Couns; 2024 Feb; 33(1):206-215. PubMed ID: 38351721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
    Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Centered Care in Breast Cancer Genetic Clinics.
    Brédart A; Anota A; Dick J; Kuboth V; Lareyre O; De Pauw A; Cano A; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S; Kop JL
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29439543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
    Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.